SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback
Authors
Keywords
DUBR, Long noncoding RNA, Stemness maintenance, Chemoresistance
Journal
CANCER LETTERS
Volume 528, Issue -, Pages 16-30
Publisher
Elsevier BV
Online
2021-12-25
DOI
10.1016/j.canlet.2021.12.026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Prognostic Signature of Immune Genes and Immune-Related LncRNAs in Neuroblastoma: A Study Based on GEO and TARGET Datasets
- (2021) Xiaodan Zhong et al. Frontiers in Oncology
- LSD1‐Demethylated LINC01134 Confers Oxaliplatin Resistance via SP1‐induced p62 Transcription in Hepatocellular Carcinoma
- (2021) Luyuan Ma et al. HEPATOLOGY
- The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia
- (2020) Wen-Tao Wang et al. Journal of Hematology & Oncology
- MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer
- (2019) Wanming He et al. ONCOGENE
- Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
- (2019) Qiang Gao et al. CELL
- LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein
- (2018) Yan Liang et al. CELL DEATH AND DIFFERENTIATION
- LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363
- (2018) Hai Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesis
- (2018) Pingping Zhu et al. NATURE CELL BIOLOGY
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Cancer Stem Cells: Basic Concepts and Therapeutic Implications
- (2016) Dany Nassar et al. Annual Review of Pathology-Mechanisms of Disease
- Cancer stem cell signaling pathways
- (2016) William H. Matsui MEDICINE
- Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1
- (2016) H Liu et al. ONCOGENE
- A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells
- (2016) Le Qu et al. Nature Communications
- LncRNA Dum interacts with Dnmts to regulate Dppa2 expression during myogenic differentiation and muscle regeneration
- (2015) Lijun Wang et al. CELL RESEARCH
- Sp1 and the ‘hallmarks of cancer’
- (2015) Kate Beishline et al. FEBS Journal
- Long noncoding RNADANCRincreases stemness features of hepatocellular carcinoma by derepression ofCTNNB1
- (2015) Sheng-xian Yuan et al. HEPATOLOGY
- Defeating EpCAM+ liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma
- (2015) Kouki Nio et al. JOURNAL OF HEPATOLOGY
- Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients
- (2015) C M Lucas et al. LEUKEMIA
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin
- (2015) Shilpi Saha et al. Translational Research
- CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway
- (2015) Juan Liu et al. TUMOR BIOLOGY
- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma
- (2014) Terence Kin-Wah Lee et al. HEPATOLOGY
- Efficacy and Safety of the FOLFOX4 Regimen Versus Doxorubicin in Chinese Patients With Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the EACH Study
- (2014) S. Qin et al. ONCOLOGIST
- Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1
- (2014) Yang Bu et al. PLoS One
- Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target
- (2013) A. Khanna et al. CANCER RESEARCH
- Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
- (2013) E. Grassilli et al. CLINICAL CANCER RESEARCH
- Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
- (2013) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1
- (2013) Anni Laine et al. Cancer Discovery
- Identification of novel Sp1 targets involved in proliferation and cancer by functional genomics
- (2012) Carlota Oleaga et al. BIOCHEMICAL PHARMACOLOGY
- Mithramycin Represses Basal and Cigarette Smoke–Induced Expression ofABCG2and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
- (2012) Mary Zhang et al. CANCER RESEARCH
- Expression of Specificity Protein Transcription Factors in Pancreatic Cancer and their Association in Prognosis and Therapy
- (2012) Umesh T. Sankpal et al. CURRENT MEDICINAL CHEMISTRY
- CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
- (2011) Terence Kin Wah Lee et al. Cell Stem Cell
- Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
- (2011) Francesco Crea et al. DRUG RESISTANCE UPDATES
- Stem cells in liver diseases and cancer: Recent advances on the path to new therapies
- (2011) C. Bart Rountree et al. HEPATOLOGY
- Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome
- (2011) Hongyu Guan et al. INTERNATIONAL JOURNAL OF CANCER
- The role of Sp1 and Sp3 in normal and cancer cell biology
- (2010) Lin Li et al. ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER
- CD13 is a therapeutic target in human liver cancer stem cells
- (2010) Naotsugu Haraguchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase II Study of Oxaliplatin in Patients With Unresectable, Metastatic, or Recurrent Hepatocellular Cancer
- (2009) Y Yen et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin
- (2009) Giovanni Luca Beretta et al. BIOCHEMICAL PHARMACOLOGY
- Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy
- (2009) Zhao-Hui Huang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sp1: Emerging roles—Beyond constitutive activation of TATA-less housekeeping genes
- (2008) Inken Wierstra BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
- (2008) Zhen Fan Yang et al. CANCER CELL
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started